General Information of the Compound
Compound ID |
CP0384767
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
4-(naphthalen-2-ylmethoxy)piperidine
Show/Hide
|
||||||||||||||||||
Synonyms |
4-(2-Naphthylmethoxy)piperidine
4-(naphthalen-2-ylmethoxy)piperidine
86811-09-8
9980ST005G
AC1L23OW
BDBM50278564
CHEMBL471036
CTK3E8854
DTXSID30235828
LITOXETINE
Litoxetina
Litoxetina [INN-Spanish]
Litoxetine
Litoxetine [INN]
Litoxetinum
Litoxetinum [INN-Latin]
SCHEMBL119884
UNII-9980ST005G
ZINC3647
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C16H19NO
|
||||||||||||||||||
Molecular Weight |
241.334
|
||||||||||||||||||
Canonical SMILES |
C(OC1CCNCC1)c1ccc2ccccc2c1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C16H19NO/c1-2-4-15-11-13(5-6-14(15)3-1)12-18-16-7-9-17-10-8-16/h1-6,11,16-17H,7-10,12H2
Show/Hide
|
||||||||||||||||||
InChIKey |
MJJDYOLPMGIWND-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
86811-09-8
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter
Clinical Information about the Compound